These factors promote TME to generate negative immune feedback by activating PI3K/Akt/mTOR, IL-6/STAT3, JAK1/STAT1/NF-κB/Notch1[15–17] signaling pathways, thereby inhibiting the innate immune response and promoting tumor proliferation and invasion. Here, NFKB1 is linked to neoplasm.